
All registrants will be sent the webinar recording shortly following the completion of the session.
During this session, you will:
Rafael Rosengarten is CEO and co-founder of Genialis, the company revolutionizing precision oncology with RNA and AI. Before leading Genialis’ effort to realize the promise of precision medicine, he spent nearly 20 years in biomedical research, publishing in the fields of evolution, immunology, bioengineering and genetics. Dr. Rosengarten is also a board member and co-founder of the Alliance for AI in Healthcare (AAIH), a non-profit global advocacy organization. Rafael attended Dartmouth College before earning his doctorate from Yale University, where he was an NSF Graduate Research Fellow, and received postdoctoral training in Jay Keasling’s synthetic biology group at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI).
Justin Guinney is the Senior Vice President of Cancer Genomics at Tempus AI where he leads research and development of precision oncology models using Tempus’s large multimodal database. Dr. Guinney retains positions as an Affiliate Associate Professor at the University of Washington, and Director of the DREAM Challenges. He received a BA in history & pre-medicine from the University of Pennsylvania, a BS in electrical engineering from the University of Illinois Urbana-Champaign, and a PhD in computational biology and bioinformatics from Duke University.